Around the Practice

A panel of experts discuss strategies for optimizing first-line therapy for transplant-ineligible patients with newly diagnosed multiple myeloma.

Experts provide their recommendations for navigating a large and continuously growing treatment landscape, selecting between regimens, and monitoring patients with transplant-ineligible multiple myeloma.

Experts in bladder cancer discuss best practices for treating patients with locally advanced and metastatic urothelial carcinoma.

Experts discuss best practices for treating patients with metastatic HER2+ breast cancer and consider optimal treatment options for patients with brain metastases and visceral disease.

Experts discuss best practices for treating patients with HER2+ breast cancer and suspected or actual brain metastases, as well as considerations for treatment sequencing and the identification and management of interstitial lung disease.

Experts in urology and nuclear medicine discuss the identification and management of biochemical recurrence in prostate cancer using 2 patient cases as examples.

Recommendations for managing 2 patient cases specific to HER2-positive metastatic breast cancer and optimizing therapy for specific patient populations within the HER2-positive space based on emerging treatments and changes to standards of care.